MedTrace Logo

Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid

NCT07478107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2026-03-20

No results posted yet for this study

Summary

In gastrointestinal malignancies peritoneal diffusion represent a severe adverse event. Current methodoly including cytology of peritoneal fluid appears insufficient. It's crucial to individuate new technology.

Conditions

  • Peritoneal Carcinomatosis

Sponsors & Collaborators

  • University of Campania Luigi Vanvitelli

    lead OTHER

Principal Investigators

  • Gennaro Galizia, MD · University of Campania Luigi Vanvitelli

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-10-31
Completion
2026-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07478107 on ClinicalTrials.gov